Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

IO Biotech, Inc. Director's Dealing 2021

Nov 5, 2021

34883_dirs_2021-11-04_aa872801-66df-44fc-83ac-a0e2d95c6087.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: IO Biotech, Inc. (IOBT)
CIK: 0001865494
Period of Report: 2021-11-04

Reporting Person: Belawat Priyanka (N/A)

More from IO Biotech, Inc.

Board/Management Information 2026
Mar 31
Delisting Announcement 2026
Feb 13
Major Shareholding Notification 2026
Feb 13
Major Shareholding Notification 2026
Feb 6
Regulatory Filings 2026
Jan 30
Major Shareholding Notification 2026
Jan 23
Regulatory Filings 2026
Jan 21
Delisting Announcement 2025
Dec 19
Board/Management Information 2025
Nov 21
Investor Presentation 2025
Nov 18
View all filings →